Summary Information:
Exact Sciences Corporation Common Stock
NASDAQ:EXAS


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Exact Sciences Corporation Common Stock
Exchange: NASDAQ
Symbol: EXAS
SEC CIK: 0001124140
Phone: 608-284-5700
5505 ENDEAVOR LANE
MADISON WI 53719

CEO: Kevin Conroy
Price when page updated: 66.19 Date: 2023-11-30
Company Website:
www.exactsciences.com

_Description: A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.

IPO YEAR:
2001
Sector:
Health Care
Industry:
Biotechnology: Commercial Physical & Biological Resarch
ADRTSO:

MarketCap:
11970457793.00
Beta:
1.154979574125108
52 Week High:
159.54
52 Week Low:
73.41
52 Week Change:
-0.44024075666380047
Short Interest:

Short Date:

Shares Outstanding:
172318821
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
1 Nov 2022
Float:
0
return on Equity:
-22.10%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$615.45
ttmEPS:
-4.85
Revenue:
$1.938B
Gross Profit:

Cash:

Debt:

Institution Percent:
93.80%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.90%
Return on Assets:
-11.20%
Return on Capital:

Profit Margin:
-37.90%
Price to Sales:
3.87
Price To Book:
2.35
Short Ratio:
4.59
PE Ratio:
-16.581853082096615
Employees:
4900
1Y Guesstimate
76.364:1.0:6




__The following are links to various summary and news pages for
__Exact Sciences Corporation Common Stock [ EXAS ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30